Ładuje się......
Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies
BACKGROUND: Immune checkpoint blockade (ICB) and BRAF(V600)-targeted therapy have demonstrated substantial clinical efficacy for patients with stage 4 melanoma in clinical trials; however, their impact on survival and barriers to treatment in the “real-life” setting remains unknown. METHODS: Patient...
Zapisane w:
| Wydane w: | Cancer Immunol Immunother |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer Berlin Heidelberg
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249064/ https://ncbi.nlm.nih.gov/pubmed/30191256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-2241-x |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|